CVRx, Inc.
General ticker "CVRX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $237.1M (TTM average)
CVRx, Inc. follows the US Stock Market performance with the rate: 12.2%.
Estimated limits based on current volatility of 3.2%: low 8.21$, high 8.75$
Factors to consider:
- Total employees count: 206 (+3.0%) as of 2024
- US accounted for 92.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Regulatory and compliance, Product liability, Strategic risks and growth management, Labor/talent shortage/retention, Acquisition/divestiture risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.49$, 11.25$]
- 2026-12-31 to 2027-12-31 estimated range: [4.02$, 10.31$]
Financial Metrics affecting the CVRX estimates:
- Negative: with PPE of -3.7 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -20.27 <= 0.01
- Positive: Investing cash flow per share per price, % of -0.29 > -0.63
- Positive: 19.40 < Shareholder equity ratio, % of 37.53 <= 42.68
- Positive: Interest expense per share per price, % of 2.94 <= 3.28
- Positive: Inventory ratio change, % of -1.37 <= -0.75
Short-term CVRX quotes
Long-term CVRX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $39.30MM | $51.29MM | $56.65MM |
| Operating Expenses | $82.40MM | $110.78MM | $107.92MM |
| Operating Income | $-43.10MM | $-59.49MM | $-51.27MM |
| Non-Operating Income | $2.05MM | $-0.42MM | $-2.06MM |
| Interest Expense | $1.80MM | $4.40MM | $5.83MM |
| R&D Expense | $11.63MM | $11.13MM | $11.13MM |
| Income(Loss) | $-41.05MM | $-59.91MM | $-53.32MM |
| Taxes | $0.15MM | $0.06MM | $0.02MM |
| Profit(Loss)* | $-41.20MM | $-59.97MM | $-53.31MM |
| Stockholders Equity | $75.95MM | $71.06MM | $39.32MM |
| Inventory | $10.98MM | $12.11MM | $12.21MM |
| Assets | $115.23MM | $133.41MM | $104.79MM |
| Operating Cash Flow | $-39.02MM | $-39.14MM | $-40.17MM |
| Capital expenditure | $0.59MM | $1.36MM | $0.58MM |
| Investing Cash Flow | $-0.59MM | $-1.36MM | $-0.58MM |
| Financing Cash Flow | $23.98MM | $55.87MM | $10.52MM |
| Earnings Per Share** | $-1.99 | $-2.65 | $-2.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.